Literature DB >> 9106370

Gender differences in health-related quality of life among postmyocardial infarction patients: brief report. CAST Investigators. Cardiac Arrhythmia Suppression Trials.

S A Shumaker1, M M Brooks, E B Schron, C Hale, J C Kellen, M Inkster, F B Wimbush, I Wiklund, M Morris.   

Abstract

Heart disease is the leading cause of death among women in the United States. The prognosis for heart disease is worse for women than for men. Also, although women are less likely than men to initially present with a myocardial infarction (MI), they are more likely to die following an MI. A number of factors have been identified that partially account for the gender difference in post-MI morbidity and mortality. However, limited data are available on the sex differences in clinical, psychosocial, and demographic factors that may combine to explain the poorer prognosis for women following an acute MI. The Cardiac Arrhythmia Suppression Trials collected detailed demographic, clinical, and psychosocial data on 2,043 men and 448 women following acute MIs. Analyses indicate that women had a worse clinical, socioeconomic, and psychosocial profile than did men. In addition, significant differences in psychosocial profiles persisted after controlling for demographic and clinical data, suggesting that women presenting with MIs have a cluster of complex factors that put them at high risk for morbidity and mortality following an MI. Future longitudinal studies that include adequate numbers of women as well as reliable assessments of both clinical and psychological variables are needed to better understand the factors that influence the poor prognosis for women with coronary heart disease.

Entities:  

Mesh:

Year:  1997        PMID: 9106370

Source DB:  PubMed          Journal:  Womens Health        ISSN: 1077-2928


  7 in total

1.  Gender differences in the trajectory of recovery in health status among young patients with acute myocardial infarction: results from the variation in recovery: role of gender on outcomes of young AMI patients (VIRGO) study.

Authors:  Rachel P Dreyer; Yongfei Wang; Kelly M Strait; Nancy P Lorenze; Gail D'Onofrio; Héctor Bueno; Judith H Lichtman; John A Spertus; Harlan M Krumholz
Journal:  Circulation       Date:  2015-04-10       Impact factor: 29.690

2.  Health-related quality of life in women and men one year after acute myocardial infarction.

Authors:  Eva Brink; Gunne Grankvist; Björn W Karlson; Lillemor R M Hallberg
Journal:  Qual Life Res       Date:  2005-04       Impact factor: 4.147

3.  Gender and drug treatment as determinants of mortality in a cohort of heart failure patients.

Authors:  A Ruigómez; S Johansson; M A Wallander; L A García Rodríguez
Journal:  Eur J Epidemiol       Date:  2001       Impact factor: 8.082

4.  Gender differences and determinants of health related quality of life in coronary patients: a follow-up study.

Authors:  María Dueñas; Carmen Ramirez; Roque Arana; Inmaculada Failde
Journal:  BMC Cardiovasc Disord       Date:  2011-05-27       Impact factor: 2.298

5.  Gender Differences in Patient-Reported Outcomes Among Adults With Atherosclerotic Cardiovascular Disease.

Authors:  Victor Okunrintemi; Javier Valero-Elizondo; Benjamin Patrick; Joseph Salami; Martin Tibuakuu; Saba Ahmad; Oluseye Ogunmoroti; Shiwani Mahajan; Safi U Khan; Martha Gulati; Khurram Nasir; Erin D Michos
Journal:  J Am Heart Assoc       Date:  2018-12-18       Impact factor: 5.501

6.  Women with coronary artery disease report worse health-related quality of life outcomes compared to men.

Authors:  Colleen M Norris; William A Ghali; P Diane Galbraith; Michelle M Graham; Louise A Jensen; Merril L Knudtson
Journal:  Health Qual Life Outcomes       Date:  2004-05-05       Impact factor: 3.186

7.  Health-related quality of life in premature acute coronary syndrome: does patient sex or gender really matter?

Authors:  Sylvie S L Leung Yinko; Roxanne Pelletier; Hassan Behlouli; Colleen M Norris; Karin H Humphries; Louise Pilote
Journal:  J Am Heart Assoc       Date:  2014-07-28       Impact factor: 5.501

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.